Eysuvis

ALCON LABORATORIES, INC.🇺🇸 United States

FDA Page

Effective Date: Mar 26, 2024
Approval ID: a2169d82-4275-4ab6-a1c3-c274080b815c
Products: 1 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use EYSUVIS™ safely and effectively. See full prescribing information for EYSUVIS. EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25%, for topical ophthalmic use Initial U.S. Approval: 1998

Quick Stats

Total Products1

Labelers2

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.